Skip to main content
PMC home page
Frontiers in Genetics logoLink to Frontiers in Genetics
editorial
. 2015 Nov 16;6:328. doi: 10.3389/fgene.2015.00328

MicroRNA Mechanisms of Action: What have We Learned from Mice?

Hyun Yong Jin 1,2, Changchun Xiao 1,*
PMCID: PMC4644800  PMID: 26635864

MicroRNAs (miRNAs) are endogenously encoded single-stranded RNAs of about 22 nucleotides (nts) in length that play essential roles in a large variety of physiological processes in animals and plants (Ambros, 2004; Bushati and Cohen, 2007). Mature miRNAs are integrated into the RNA-induced silencing complex (RISC), whose core component is one of the Argonaute family proteins. MiRNAs then direct RISCs to target mRNAs, which are recognized through partial sequence complementarity. Bioinformatic prediction and experimental target gene identification have shown that a miRNA binds mRNAs of hundreds of protein coding genes, which often span a broad spectrum of functional categories (Bartel, 2009; Chi et al., 2009; Hafner et al., 2010). The functional consequence of miRNA-target mRNA interaction and the mechanism of miRNA action have been under intensive investigation and remain a matter of hot debate. It was initially thought that miRNAs repress the protein output of a small number of target genes without significantly affecting their mRNA levels in animals (Lee et al., 1993; Wightman et al., 1993). Subsequent genetic studies in C. elegans and zebrafish showed that miRNAs promote the degradation of their target mRNAs (Bagga et al., 2005; Giraldez et al., 2006). Later, a series of genome-wide studies of in vitro cultured mammalian cell lines transiently transfected with chemically synthesized miRNA mimics led to the conclusion that the predominant functional consequence of miRNA action is target mRNA degradation (Guo et al., 2010). A follow-up study employing temporal dissection of zebrafish development seems to reconcile these two opposite observations by revealing that translational repression precedes target mRNA decay, and suggesting that the immediate outcome of miRNA-target mRNA interaction is translation inhibition but mRNA degradation can follow (Bazzini et al., 2012). Similarly, re-analysis of the previous datasets from cultured cell lines transiently transfected with synthetic miRNA mimics also found that translation repression precedes mRNA degradation (Larsson and Nadon, 2013).

However, the model miRNA used in the aforementioned zebrafish study, miR-430, is unique in that its expression is rapidly induced and reaches millions of copies per cell in a few hours after fertilization. This expression level of miR-430 is at least 10 times more than all mature miRNAs combined in a mammalian cell, and serves the single purpose of degrading its target genes, maternal mRNAs, at the maternal-zygotic transition (Giraldez et al., 2006). Mammalian cells often express 100–200 different species of miRNAs (Kuchen et al., 2010), with a total amount of 1–2 × 105 copies of mature miRNAs in a cell (Calabrese et al., 2007; Janas et al., 2012). The most abundant miRNAs are often expressed at the level of ~2 × 104 copies per cell (Neilson et al., 2007; Kuchen et al., 2010). As an extreme example, miR-122 is expressed at the estimated level of 5 × 104 copies per cell in hepatocytes (Chang et al., 2004; Jopling et al., 2005). This is still about 20 times lower than the million-copy-per-cell expression level of miR-430 in zebrafish embryos. Considering that the estimated copy number of Argonaute proteins in a mammalian cell is of the same order of magnitude as the total amount of mature miRNAs (1.5 × 104–1.7 × 105; Janas et al., 2012; Wang et al., 2012), the million-copy-per-cell expression level of miR-430 is unlikely to be physiologically relevant in mammalian cells. Therefore, the in vivo mechanism of action of mammalian miRNAs remains to be a central question in the field of miRNA research.

In contrast to these desperate efforts to search for a unified model of miRNA mechanism of action, studies of individual functional targets in primary cells or tissues from miRNA mutant mice are painting a rather different picture. Depending on miRNAs, target genes, and cellular contexts, the outcome of miRNA-target mRNA interactions could be predominantly translation repression or mRNA degradation, or a mixture of both. This heterogeneity in miRNA mechanisms of action has been increasingly recognized as more and more miRNA mutant mice are generated and analyzed (Olive et al., 2015), but a comprehensive review of relevant literature is still missing.

Here we sought to summarize the relative contribution of translation repression and mRNA degradation to miRNA regulation of functional targets in miRNA mutant mice. We focused on miRNA target genes whose protein and mRNA levels were measured concurrently in primary cells or tissues from mutant mice with genetic ablation or transgenic expression of individual miRNA genes. This includes a total of 159 target genes from 77 miRNA mutant mice (Table S1; Zhao et al., 2005, 2007; Lu et al., 2007, 2009, 2014; van Rooij et al., 2007; Vigorito et al., 2007; Dorsett et al., 2008; Liu et al., 2008, 2011, 2012, 2014; Wang et al., 2008, 2013a,b, 2014, 2015a,b; Boettger et al., 2009; Callis et al., 2009; O'Connell et al., 2009, 2010; Poy et al., 2009; Shan et al., 2009; Williams et al., 2009; Xin et al., 2009; Miyaki et al., 2010; Patrick et al., 2010; Yu et al., 2010; Biton et al., 2011; Boldin et al., 2011; Dunand-Sauthier et al., 2011; Jiang et al., 2011; Jordan et al., 2011; Ma et al., 2011, 2013; Nakamura et al., 2011; Sanuki et al., 2011; Shibata et al., 2011; Aurora et al., 2012; Callegari et al., 2012; Caruso et al., 2012; Dong et al., 2012; Gurha et al., 2012; Horie et al., 2012, 2013; Hsu et al., 2012; Liang et al., 2012, 2015; Mori et al., 2012; Tsai et al., 2012; Ucar et al., 2012; Wei et al., 2012, 2014; Zhuang et al., 2012; Belkaya et al., 2013; Bian et al., 2013; Danielson et al., 2013; Dorhoi et al., 2013; Dudda et al., 2013; Gebeshuber et al., 2013; Guo et al., 2013; Hasuwa et al., 2013; Heidersbach et al., 2013; Henao-Mejia et al., 2013; Khan et al., 2013; Mok et al., 2013; Song et al., 2013, 2014; Stadthagen et al., 2013; Tan et al., 2013; Wystub et al., 2013; Agudo et al., 2014; Ahmed et al., 2014; Burger et al., 2014; Chapnik et al., 2014; Dahan et al., 2014; Escobar et al., 2014; Giusti et al., 2014; Hu et al., 2014; Krzeszinski et al., 2014; Latreille et al., 2014; Pan et al., 2014; Stickel et al., 2014; Cushing et al., 2015; Jin et al., 2015; Kosaka et al., 2015; Kramer et al., 2015; Li et al., 2015a,b,c; Parchem et al., 2015; Sullivan et al., 2015; Sun et al., 2015; Tung et al., 2015; Xu et al., 2015; Yan et al., 2015; Zhang et al., 2015). Our analysis showed that 48% target genes are predominantly regulated by translation repression (76/159), 29% are regulated mainly by mRNA degradation (46/159), and 23% are regulated by both (37/159) (Figure 1). It is still unclear what determines the dominant mode of miRNA mechanism of action. As most of these studies measured target gene mRNA and protein levels under steady-state conditions, we speculate that differences in miRNA mechanism of action are not solely determined by the expression kinetics of miRNA or target mRNAs (Bazzini et al., 2012; Béthune et al., 2012; Djuranovic et al., 2012), but are instead attributed to cell type-, target mRNA-, or even miRNA-specific factors. Interestingly, almost all target genes identified in developing cells or tissues are mainly regulated by mRNA degradation, such as day 0 or day 2.5 cardiac cells (Heidersbach et al., 2013; Wei et al., 2014), embryonic stem cell-derived neurons (Tung et al., 2015), thymocytes (Belkaya et al., 2013; Henao-Mejia et al., 2013; Burger et al., 2014), bone marrow cells (Song et al., 2013), embryonic heart (Wystub et al., 2013; Liang et al., 2015), embryonic yolk sac (Wang et al., 2008), embryonic and neonatal epithelium (Ahmed et al., 2014), and fetal liver (Patrick et al., 2010). This is in sharp contrast to target genes identified in terminally differentiated cells, which are predominantly regulated by translation repression. It is conceivable that mRNA degradation gets rid of target gene mRNAs in a non-reversible way and provides an efficient way for cell fate determination, while translation repression is immediate, transient, and reversible, which is more suitable for differentiated cells to respond to environmental stresses. Our analysis also suggests miRNA-specific functional consequences. Several groups independently observed that target genes of miR-17~92 (Lu et al., 2007; Shan et al., 2009; Jiang et al., 2011; Bian et al., 2013; Danielson et al., 2013; Jin et al., 2015), miR-214 (Aurora et al., 2012; Wang et al., 2013b; Li et al., 2015b), miR-143/145 (Boettger et al., 2009; Jordan et al., 2011; Caruso et al., 2012; Dahan et al., 2014), and miR-146 (Boldin et al., 2011; Guo et al., 2013; Stickel et al., 2014) tend to be regulated at the translational level, but target genes of miR-122 (Hsu et al., 2012; Tsai et al., 2012), miR-140 (Miyaki et al., 2010; Nakamura et al., 2011) and miR-142 (Chapnik et al., 2014; Kramer et al., 2015; Sun et al., 2015) are often regulated by mRNA degradation. Interestingly, among miR-155 target genes, some are predominantly regulated by translation repression, some are mainly regulated by mRNA degradation, while the others are regulated by both mechanisms (Vigorito et al., 2007; Dorsett et al., 2008; Lu et al., 2009, 2014; O'Connell et al., 2009, 2010; Dudda et al., 2013; Escobar et al., 2014; Hu et al., 2014; Jin et al., 2015; Wang et al., 2015a), suggesting that different target genes of the same miRNA can be regulated through different mechanisms even in the same cell. It is a tempting possibility that cis-elements in mature miRNAs and target mRNAs determine the mechanism of miRNA action. Future investigation is warranted to identify these cis-elements, if they exist at all.

Figure 1.

Figure 1

Open in a new tab

Contribution of translation repression and mRNA degradation to miRNA regulation of target gene expression in primary cells and tissues from miRNA mutant mice. Number in parentheses indicates the number of genes in each category. See also Table S1 for detailed information.

From a practical standpoint, measuring target gene protein levels is preferred to mRNA levels for the purpose of studying the effect of a miRNA on its target genes. Even for target genes predominantly regulated by mRNA degradation, the miRNA effect can still be captured by measuring their protein abundance. In the same vein, translatome analysis is more appropriate for measuring the global effect of a miRNA on its target genes, while transcriptome analysis often failed to identify any significant effect of miRNA deletion on its target genes, despite the obvious functional consequences in mutant mice (Matkovich et al., 2010; Boldin et al., 2011; Jiang et al., 2011; Agudo et al., 2014; Sullivan et al., 2015; Yuan et al., 2015). In the broader context of gene expression regulation, accumulating evidence shows that proteome and transcriptome are not sufficiently correlated to act as proxies for each other (Payne, 2015). miRNA-mediated translation regulation may play an important role in the de-coupling of translatome from transcriptome. We speculate that miRNAs emerged during evolution to increase the complexity of gene regulation, thereby contributing to the diversity of organisms.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Dr. Li-Fan Lu (UCSD) for discussion and Jovan Shepherd for critical reading of this manuscript. This study is supported by the PEW Charitable Trusts, Cancer Research Institute, Lupus Research Institute, and National Institute of Health (R01AI087634, R01AI089854, and R56 AI110403 to CX). CX is a Pew Scholar in Biomedical Sciences.

Supplementary material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fgene.2015.00328

Click here for additional data file. (119.6KB, PDF)

References

  1. Agudo J., Ruzo A., Tung N., Salmon H., Leboeuf M., Hashimoto D., et al. (2014). The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nat. Immunol. 15, 54–62. 10.1038/ni.2767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed M. I., Alam M., Emelianov V. U., Poterlowicz K., Patel A., Sharov A. A., et al. (2014). MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway. J. Cell Biol. 207, 549–567. 10.1083/jcb.201404001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ambros V. (2004). The functions of animal microRNAs. Nature 431, 350–355. 10.1038/nature02871 [DOI] [PubMed] [Google Scholar]
  4. Aurora A. B., Mahmoud A. I., Luo X., Johnson B. A., van Rooij E., Matsuzaki S., et al. (2012). MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J. Clin. Invest. 122, 1222–1232. 10.1172/JCI59327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bagga S., Bracht J., Hunter S., Massirer K., Holtz J., Eachus R., et al. (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122, 553–563. 10.1016/j.cell.2005.07.031 [DOI] [PubMed] [Google Scholar]
  6. Bartel D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233. 10.1016/j.cell.2009.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bazzini A. A., Lee M. T., Giraldez A. J. (2012). Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336, 233–237. 10.1126/science.1215704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Belkaya S., Murray S. E., Eitson J. L., de la Morena M. T., Forman J. A., van Oers N. S. (2013). Transgenic expression of microRNA-185 causes a developmental arrest of T cells by targeting multiple genes including Mzb1. J. Biol. Chem. 288, 30752–30762. 10.1074/jbc.M113.503532 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Béthune J., Artus-Revel C. G., Filipowicz W. (2012). Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep. 13, 716–723. 10.1038/embor.2012.82 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bian S., Hong J., Li Q., Schebelle L., Pollock A., Knauss J. L., et al. (2013). MicroRNA cluster miR-17-92 regulates neural stem cell expansion and transition to intermediate progenitors in the developing mouse neocortex. Cell Rep. 3, 1398–1406. 10.1016/j.celrep.2013.03.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Biton M., Levin A., Slyper M., Alkalay I., Horwitz E., Mor H., et al. (2011). Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat. Immunol. 12, 239–246. 10.1038/ni.1994 [DOI] [PubMed] [Google Scholar]
  12. Boettger T., Beetz N., Kostin S., Schneider J., Krüger M., Hein L., et al. (2009). Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119, 2634–2647. 10.1172/JCI38864 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Boldin M. P., Taganov K. D., Rao D. S., Yang L., Zhao J. L., Kalwani M., et al. (2011). miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189–1201. 10.1084/jem.20101823 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Burger M. L., Xue L., Sun Y., Kang C., Winoto A. (2014). Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation. Blood 123, 4089–4100. 10.1182/blood-2013-11-539411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bushati N., Cohen S. M. (2007). microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175–205. 10.1146/annurev.cellbio.23.090506.123406 [DOI] [PubMed] [Google Scholar]
  16. Calabrese J. M., Seila A. C., Yeo G. W., Sharp P. A. (2007). RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 104, 18097–18102. 10.1073/pnas.0709193104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Callegari E., Elamin B. K., Giannone F., Milazzo M., Altavilla G., Fornari F., et al. (2012). Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 56, 1025–1033. 10.1002/hep.25747 [DOI] [PubMed] [Google Scholar]
  18. Callis T. E., Pandya K., Seok H. Y., Tang R. H., Tatsuguchi M., Huang Z. P., et al. (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772–2786. 10.1172/JCI36154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Caruso P., Dempsie Y., Stevens H. C., McDonald R. A., Long L., Lu R., et al. (2012). A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ. Res. 111, 290–300. 10.1161/CIRCRESAHA.112.267591 [DOI] [PubMed] [Google Scholar]
  20. Chang J., Nicolas E., Marks D., Sander C., Lerro A., Buendia M. A., et al. (2004). miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1, 106–113. 10.4161/rna.1.2.1066 [DOI] [PubMed] [Google Scholar]
  21. Chapnik E., Rivkin N., Mildner A., Beck G., Pasvolsky R., Metzl-Raz E., et al. (2014). miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. Elife 3:e01964. 10.7554/eLife.01964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chi S. W., Zang J. B., Mele A., Darnell R. B. (2009). Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479–486. 10.1038/nature08170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Cushing L., Costinean S., Xu W., Jiang Z., Madden L., Kuang P., et al. (2015). Disruption of miR-29 leads to aberrant differentiation of smooth muscle cells selectively associated with distal lung vasculature. PLoS Genet. 11:e1005238. 10.1371/journal.pgen.1005238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dahan D., Ekman M., Larsson-Callerfelt A. K., Turczynska K., Boettger T., Braun T., et al. (2014). Induction of angiotensin-converting enzyme after miR-143/145 deletion is critical for impaired smooth muscle contractility. Am. J. Physiol. Cell Physiol. 307, C1093–C1101. 10.1152/ajpcell.00250.2014 [DOI] [PubMed] [Google Scholar]
  25. Danielson L. S., Park D. S., Rotllan N., Chamorro-Jorganes A., Guijarro M. V., Fernandez-Hernando C., et al. (2013). Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 27, 1460–1467. 10.1096/fj.12-221994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Djuranovic S., Nahvi A., Green R. (2012). miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 336, 237–240. 10.1126/science.1215691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Dong C., Wang H., Xue L., Dong Y., Yang L., Fan R., et al. (2012). Coat color determination by miR-137 mediated down-regulation of microphthalmia-associated transcription factor in a mouse model. RNA 18, 1679–1686. 10.1261/rna.033977.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Dorhoi A., Iannaccone M., Farinacci M., Faé K. C., Schreiber J., Moura-Alves P., et al. (2013). MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. J. Clin. Invest. 123, 4836–4848. 10.1172/JCI67604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Dorsett Y., McBride K. M., Jankovic M., Gazumyan A., Thai T. H., Robbiani D. F., et al. (2008). MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28, 630–638. 10.1016/j.immuni.2008.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Dudda J. C., Salaun B., Ji Y., Palmer D. C., Monnot G. C., Merck E., et al. (2013). MicroRNA-155 is required for effector CD8(+) T cell responses to virus infection and cancer. Immunity 38, 742–753. 10.1016/j.immuni.2012.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Dunand-Sauthier I., Santiago-Raber M. L., Capponi L., Vejnar C. E., Schaad O., Irla M., et al. (2011). Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood 117, 4490–4500. 10.1182/blood-2010-09-308064 [DOI] [PubMed] [Google Scholar]
  32. Escobar T. M., Kanellopoulou C., Kugler D. G., Kilaru G., Nguyen C. K., Nagarajan V., et al. (2014). miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein jarid2 to relieve polycomb-mediated repression. Immunity 40, 865–879. 10.1016/j.immuni.2014.03.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Gebeshuber C. A., Kornauth C., Dong L., Sierig R., Seibler J., Reiss M., et al. (2013). Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat. Med. 19, 481–487. 10.1038/nm.3142 [DOI] [PubMed] [Google Scholar]
  34. Giraldez A. J., Mishima Y., Rihel J., Grocock R. J., Van Dongen S., Inoue K., et al. (2006). Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312, 75–79. 10.1126/science.1122689 [DOI] [PubMed] [Google Scholar]
  35. Giusti S. A., Vogl A. M., Brockmann M. M., Vercelli C. A., Rein M. L., Trumbach D., et al. (2014). MicroRNA-9 controls dendritic development by targeting REST. Elife 3:e02755. 10.7554/eLife.02755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Guo H., Ingolia N. T., Weissman J. S., Bartel D. P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840. 10.1038/nature09267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Guo Q., Zhang J., Li J., Zou L., Zhang J., Xie Z., et al. (2013). Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of fas in germinal center B cells. Blood 121, 4875–4883. 10.1182/blood-2012-08-452425 [DOI] [PubMed] [Google Scholar]
  38. Gurha P., Abreu-Goodger C., Wang T., Ramirez M. O., Drumond A. L., van Dongen S., et al. (2012). Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 125, 2751–2761. 10.1161/CIRCULATIONAHA.111.044354 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., et al. (2010). Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141. 10.1016/j.cell.2010.03.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Hasuwa H., Ueda J., Ikawa M., Okabe M. (2013). MiR-200b and miR-429 function in mouse ovulation and are essential for female fertility. Science 341, 71–73. 10.1126/science.1237999 [DOI] [PubMed] [Google Scholar]
  41. Heidersbach A., Saxby C., Carver-Moore K., Huang Y., Ang Y. S., de Jong P. J., et al. (2013). microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife 2:e01323. 10.7554/eLife.01323 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Henao-Mejia J., Williams A., Goff L. A., Staron M., Licona-Limón P., Kaech S. M., et al. (2013). The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38, 984–997. 10.1016/j.immuni.2013.02.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Horie T., Baba O., Kuwabara Y., Chujo Y., Watanabe S., Kinoshita M., et al. (2012). MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in apoE(-/-) mice. J. Am. Heart Assoc. 1:e003376. 10.1161/JAHA.112.003376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Horie T., Nishino T., Baba O., Kuwabara Y., Nakao T., Nishiga M., et al. (2013). MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat. Commun. 4, 2883. 10.1038/ncomms3883 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hsu S. H., Wang B., Kota J., Yu J., Costinean S., Kutay H., et al. (2012). Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122, 2871–2883. 10.1172/JCI63539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hu R., Kagele D. A., Huffaker T. B., Runtsch M. C., Alexander M., Liu J., et al. (2014). miR-155 promotes t follicular helper cell accumulation during chronic, low-grade inflammation. Immunity 41, 605–619. 10.1016/j.immuni.2014.09.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Janas M. M., Wang B., Harris A. S., Aguiar M., Shaffer J. M., Subrahmanyam Y. V., et al. (2012). Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. RNA 18, 2041–2055. 10.1261/rna.035675.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Jiang S., Li C., Olive V., Lykken E., Feng F., Sevilla J., et al. (2011). Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118, 5487–5497. 10.1182/blood-2011-05-355644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Jin H. Y., Gonzalez-Martin A., Miletic A., Lai M., Knight S., Sabouri-Ghomi M., et al. (2015). Transfection of microRNA mimics should be used with caution. Front. Genet. 6:340 10.3389/fgene.2015.00340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Jopling C. L., Yi M., Lancaster A. M., Lemon S. M., Sarnow P. (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577–1581. 10.1126/science.1113329 [DOI] [PubMed] [Google Scholar]
  51. Jordan S. D., Kruger M., Willmes D. M., Redemann N., Wunderlich F. T., Bronneke H. S., et al. (2011). Obesity-induced over expression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 13, 434. 10.1038/ncb2211 [DOI] [PubMed] [Google Scholar]
  52. Khan A. A., Penny L. A., Yuzefpolskiy Y., Sarkar S., Kalia V. (2013). MicroRNA-17~92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections. Blood 121, 4473–4483. 10.1182/blood-2012-06-435412 [DOI] [PubMed] [Google Scholar]
  53. Kosaka A., Ohkuri T., Ikeura M., Kohanbash G., Okada H. (2015). Transgene-derived overexpression of miR-17-92 in CD8(+) T-cells confers enhanced cytotoxic activity. Biochem. Biophys. Res. Commun. 458, 549–554. 10.1016/j.bbrc.2015.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Kramer N. J., Wang W. L., Reyes E. Y., Kumar B., Chen C. C., Ramakrishna C., et al. (2015). Altered lymphopoiesis and immunodeficiency in miR-142 null mice. Blood 125, 3720–3730. 10.1182/blood-2014-10-603951 [DOI] [PubMed] [Google Scholar]
  55. Krzeszinski J. Y., Wei W., Huynh H., Jin Z., Wang X., Chang T. C., et al. (2014). miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature 512, 431–U460. 10.1038/nature13375 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  56. Kuchen S., Resch W., Yamane A., Kuo N., Li Z., Chakraborty T., et al. (2010). Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32, 828–839. 10.1016/j.immuni.2010.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Larsson O., Nadon R. (2013). Re-analysis of genome wide data on mammalian microRNA-mediated suppression of gene expression. Translation 1:e24557 10.4161/trla.24557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Latreille M., Hausser J., Stützer I., Zhang Q., Hastoy B., Gargani S., et al. (2014). MicroRNA-7a regulates pancreatic beta cell function. J. Clin. Invest. 124, 2722–2735. 10.1172/JCI73066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Lee R. C., Feinbaum R. L., Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854. 10.1016/0092-8674(93)90529-Y [DOI] [PubMed] [Google Scholar]
  60. Li C. J., Cheng P., Liang M. K., Chen Y. S., Lu Q., Wang J. Y., et al. (2015a). MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Invest. 125, 1509–1522. 10.1172/JCI77716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Li K., Zhang J., Yu J., Liu B., Guo Y., Deng J., et al. (2015b). MicroRNA-214 suppresses gluconeogenesis by targeting activating transcriptional factor 4. J. Biol. Chem. 290, 8185–8195. 10.1074/jbc.M114.633990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Li Z., Chen P., Su R., Li Y., Hu C., Wang Y., et al. (2015c). Overexpression and knockout of miR-126 both promote leukemogenesis through targeting distinct gene signaling. Blood 126, 2005–2015. 10.1182/blood-2015-04-639062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Liang C., Zhu H., Xu Y., Huang L., Ma C., Deng W., et al. (2012). MicroRNA-153 negatively regulates the expression of amyloid precursor protein and amyloid precursor-like protein 2. Brain Res. 1455, 103–113. 10.1016/j.brainres.2011.10.051 [DOI] [PubMed] [Google Scholar]
  64. Liang D., Li J., Wu Y., Zhen L., Li C., Qi M., et al. (2015). miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2. Int. J. Cardiol. 201, 38–48. 10.1016/j.ijcard.2015.06.163 [DOI] [PubMed] [Google Scholar]
  65. Liu N., Bezprozvannaya S., Shelton J. M., Frisard M. I., Hulver M. W., McMillan R. P., et al. (2011). Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J. Clin. Invest. 121, 3258–3268. 10.1172/JCI46267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Liu N., Bezprozvannaya S., Williams A. H., Qi X., Richardson J. A., Bassel-Duby R., et al. (2008). microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242–3254. 10.1101/gad.1738708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Liu N., Williams A. H., Maxeiner J. M., Bezprozvannaya S., Shelton J. M., Richardson J. A., et al. (2012). microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 122, 2054–2065. 10.1172/JCI62656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Liu S. Q., Jiang S., Li C., Zhang B., Li Q. J. (2014). miR-17-92 cluster targets phosphatase and tensin homology and ikaros family zinc finger 4 to promote TH17-mediated inflammation. J. Biol. Chem. 289, 12446–12456. 10.1074/jbc.M114.550723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Lu D., Nakagawa R., Lazzaro S., Staudacher P., Abreu-Goodger C., Henley T., et al. (2014). The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. J. Exp. Med. 211, 2183–2198. 10.1084/jem.20140338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Lu L. F., Thai T. H., Calado D. P., Chaudhry A., Kubo M., Tanaka K., et al. (2009). Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80–91. 10.1016/j.immuni.2008.11.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Lu Y., Thomson J. M., Wong H. Y., Hammond S. M., Hogan B. L. (2007). Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310, 442–453. 10.1016/j.ydbio.2007.08.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Ma W., Hu S., Yao G., Xie S., Ni M., Liu Q., et al. (2013). An androgen receptor-microrna-29a regulatory circuitry in mouse epididymis. J. Biol. Chem. 288, 29369–29381. 10.1074/jbc.M113.454066 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Ma X. D., Kumar M., Choudhury S. N., Becker Buscaglia L. E., Barker J. R., Kanakamedala K., et al. (2011). Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 10144–10149. 10.1073/pnas.1103735108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Matkovich S. J., Wang W., Tu Y., Eschenbacher W. H., Dorn L. E., Condorelli G., et al. (2010). MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ. Res. 106, 166–175. 10.1161/CIRCRESAHA.109.202176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Miyaki S., Sato T., Inoue A., Otsuki S., Ito Y., Yokoyama S., et al. (2010). MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 24, 1173–1185. 10.1101/gad.1915510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Mok Y., Schwierzeck V., Thomas D. C., Vigorito E., Rayner T. F., Jarvis L. B., et al. (2013). MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production. J. Immunol. 191, 3037–3048. 10.4049/jimmunol.1301289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Mori M., Nakagami H., Rodriguez-Araujo G., Nimura K., Kaneda Y. (2012). Essential role for miR-196a in brown adipogenesis of white fat progenitor cells. PLoS Biol. 10:e1001314. 10.1371/journal.pbio.1001314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Nakamura Y., Inloes J. B., Katagiri T., Kobayashi T. (2011). Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets dnpep to modulate bone morphogenetic protein signaling. Mol. Cell. Biol. 31, 3019–3028. 10.1128/MCB.05178-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Neilson J. R., Zheng G. X. Y., Burge C. B., Sharp P. A. (2007). Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21, 578–589. 10.1101/gad.1522907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. O'Connell R. M., Chaudhuri A. A., Rao D. S., Baltimore D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U.S.A. 106, 7113–7118. 10.1073/pnas.0902636106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. O'Connell R. M., Kahn D., Gibson W. S., Round J. L., Scholz R. L., Chaudhuri A. A., et al. (2010). MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607–619. 10.1016/j.immuni.2010.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Olive V., Minella A. C., He L. (2015). Outside the coding genome, mammalian microRNAs confer structural and functional complexity. Sci. Signal. 8, re2. 10.1126/scisignal.2005813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Pan D., Mao C., Quattrochi B., Friedline R. H., Zhu L. J., Jung D. Y., et al. (2014). MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat. Commun. 5, 4725. 10.1038/ncomms5725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Parchem R. J., Moore N., Fish J. L., Parchem J. G., Braga T. T., Shenoy A., et al. (2015). miR-302 is required for timing of neural differentiation, neural tube closure, and embryonic viability. Cell Rep. 12, 760–773. 10.1016/j.celrep.2015.06.074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Patrick D. M., Zhang C. C., Tao Y., Yao H., Qi X., Schwartz R. J., et al. (2010). Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev. 24, 1614–1619. 10.1101/gad.1942810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Payne S. H. (2015). The utility of protein and mRNA correlation. Trends Biochem. Sci. 40, 1–3. 10.1016/j.tibs.2014.10.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Poy M. N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., et al. (2009). miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl. Acad. Sci. U.S.A. 106, 5813–5818. 10.1073/pnas.0810550106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Sanuki R., Onishi A., Koike C., Muramatsu R., Watanabe S., Muranishi Y., et al. (2011). miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat. Neurosci. 14, 1125–1134. 10.1038/nn.2897 [DOI] [PubMed] [Google Scholar]
  89. Shan S. W., Lee D. Y., Deng Z., Shatseva T., Jeyapalan Z., Du W. W., et al. (2009). MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 11, 1031–1038. 10.1038/ncb1917 [DOI] [PubMed] [Google Scholar]
  90. Shibata M., Nakao H., Kiyonari H., Abe T., Aizawa S. (2011). MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J. Neurosci. 31, 3407–3422. 10.1523/JNEUROSCI.5085-10.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Song R., Walentek P., Sponer N., Klimke A., Lee J. S., Dixon G., et al. (2014). miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature 510, 115. 10.1038/nature13413 [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Song S. J., Ito K., Ala U., Kats L., Webster K., Sun S. M., et al. (2013). The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13, 87–101. 10.1016/j.stem.2013.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Stadthagen G., Tehler D., Høyland-Kroghsbo N. M., Wen J., Krogh A., Jensen K. T., et al. (2013). Loss of miR-10a activates lpo and collaborates with activated Wnt signaling in inducing intestinal neoplasia in female mice. PLoS Genet. 9:e1003913. 10.1371/journal.pgen.1003913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Stickel N., Prinz G., Pfeifer D., Hasselblatt P., Schmitt-Graeff A., Follo M., et al. (2014). MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD. Blood 124, 2586–2595. 10.1182/blood-2014-04-569046 [DOI] [PubMed] [Google Scholar]
  95. Sullivan R. P., Leong J. W., Schneider S. E., Ireland A. R., Berrien-Elliott M. M., Singh A., et al. (2015). MicroRNA-15/16 antagonizes Myb to control NK cell maturation. J. Immunol. 195, 2806–2817. 10.4049/jimmunol.1500949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Sun Y., Oravecz-Wilson K., Mathewson N., Wang Y., McEachin R., Liu C., et al. (2015). Mature T cell responses are controlled by microRNA-142. J. Clin. Invest. 125, 2825–2840. 10.1172/JCI78753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Tan C. L., Plotkin J. L., Venø M. T., Von Schimmelmann M., Feinberg P., Mann S., et al. (2013). MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342, 1254–1258. 10.1126/science.1244193 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Tsai W. C., Hsu S. D., Hsu C. S., Lai T. C., Chen S. J., Shen R., et al. (2012). MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122, 2884–2897. 10.1172/JCI63455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Tung Y. T., Lu Y. L., Peng K. C., Yen Y. P., Chang M., Li J., et al. (2015). Mir-17 ~ 92 governs motor neuron subtype survival by mediating nuclear pten. Cell Rep. 11, 1305–1318. 10.1016/J.Celrep.2015.04.050 [DOI] [PubMed] [Google Scholar]
  100. Ucar A., Gupta S. K., Fiedler J., Erikci E., Kardasinski M., Batkai S., et al. (2012). The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat. Commun. 3, 1078. 10.1038/ncomms2090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. van Rooij E., Sutherland L. B., Qi X., Richardson J. A., Hill J., Olson E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575–579. 10.1126/science.1139089 [DOI] [PubMed] [Google Scholar]
  102. Vigorito E., Perks K. L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., et al. (2007). microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27, 847–859. 10.1016/j.immuni.2007.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Wang D., Zhang Z., O'Loughlin E., Lee T., Houel S., O'Carroll D., et al. (2012). Quantitative functions of Argonaute proteins in mammalian development. Genes Dev. 26, 693–704. 10.1101/gad.182758.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Wang D., Zhang Z., O'Loughlin E., Wang L., Fan X., Lai E. C., et al. (2013a). MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathway. Nat. Cell Biol. 15, 1153–1163. 10.1038/ncb2827 [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Wang H. P., Flach H., Onizawa M., Wei L., McManus M. T., Weiss A. (2014). Negative regulation of hif1a expression and T(H)17 differentiation by the hypoxia-regulated microRNA miR-210. Nat. Immunol. 15, 393. 10.1038/ni.2846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Wang J., Yu F., Jia X., Iwanowycz S., Wang Y., Huang S., et al. (2015a). MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth. Int. J. Cancer 136, E602–E613. 10.1002/ijc.29151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Wang K., Liu C. Y., Zhang X. J., Feng C., Zhou L. Y., Zhao Y., et al. (2015b). MiR-361-regulated prohibitin inhibits mitochondrial fission and apoptosis and protects heart from ischemia injury. Cell Death Differ. 22, 1058–1068. 10.1038/cdd.2014.200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Wang S. S., Aurora A. B., Johnson B. A., Qi X., McAnally J., Hill J. A., et al. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261–271. 10.1016/j.devcel.2008.07.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Wang X., Guo B., Li Q., Peng J., Yang Z., Wang A., et al. (2013b). MiR-214 targets ATF4 to inhibit bone formation. Nat. Med. 19, 93–100. 10.1038/nm.3026 [DOI] [PubMed] [Google Scholar]
  110. Wei J., Shi Y., Zheng L., Zhou B., Inose H., Wang J., et al. (2012). MiR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J. Cell Biol. 197, 509–521. 10.1083/jcb.201201057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Wei Y., Peng S., Wu M., Sachidanandam R., Tu Z., Zhang S., et al. (2014). Multifaceted roles of miR-1s in repressing the fetal gene program in the heart. Cell Res. 24, 278–292. 10.1038/cr.2014.12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Wightman B., Ha I., Ruvkun G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855–862. 10.1016/0092-8674(93)90530-4 [DOI] [PubMed] [Google Scholar]
  113. Williams A. H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J. L., et al. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549–1554. 10.1126/science.1181046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Wystub K., Besser J., Bachmann A., Boettger T., Braun T. (2013). miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development. PLoS Genet. 9:e1003793. 10.1371/journal.pgen.1003793 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Xin M., Small E. M., Sutherland L. B., Qi X., McAnally J., Plato C. F., et al. (2009). MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166–2178. 10.1101/gad.1842409 [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Xu S., Ou X., Huo J., Lim K., Huang Y., Chee S., et al. (2015). Mir-17-92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c. Nat. Commun. 6, 6764. 10.1038/ncomms7764 [DOI] [PubMed] [Google Scholar]
  117. Yan S., Xu Z., Lou F., Zhang L., Ke F., Bai J., et al. (2015). NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat. Commun. 6, 7652. 10.1038/ncomms8652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Yu D., dos Santos C. O., Zhao G., Jiang J., Amigo J. D., Khandros E., et al. (2010). miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 24, 1620–1633. 10.1101/gad.1942110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Yuan S., Tang C., Zhang Y., Wu J., Bao J., Zheng H., et al. (2015). Mir-34b/c and mir-449a/b/c are required for spermatogenesis, but not for the first cleavage division in mice. Biol. Open 4, 212–223. 10.1242/bio.201410959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Zhang L., Ke F., Liu Z., Bai J., Liu J., Yan S., et al. (2015). MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3. Nat. Commun. 6, 7639. 10.1038/ncomms8639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Zhao Y., Ransom J. F., Li A., Vedantham V., von Drehle M., Muth A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303–317. 10.1016/j.cell.2007.03.030 [DOI] [PubMed] [Google Scholar]
  122. Zhao Y., Samal E., Srivastava D. (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214–220. 10.1038/nature03817 [DOI] [PubMed] [Google Scholar]
  123. Zhuang G., Meng C., Guo X., Cheruku P. S., Shi L., Xu H., et al. (2012). A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 125, 2892–2903. 10.1161/CIRCULATIONAHA.111.087817 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (119.6KB, PDF)

Articles from Frontiers in Genetics are provided here courtesy of Frontiers Media SA

RESOURCES